Outcome of polyomavirus nephropathy in renal transplant patients: a single-center experience

• Published in: Clinical nephrology Vol. 88; no. 13; pp. 109 - 114
• Main Authors: Kojc, Nika, Aleš Rigler, Andreja, Mlinšek, Gregor, Kovač, Damjan, Ferluga, Dušan, Arnol, Miha
• Format: Journal Article
• Language: English
• Published: Germany 2017
• Subjects: Adult; Aged; Biopsy; BK Virus - isolation & purification; Female; Graft Rejection - pathology; Humans; Immunosuppression; Kidney - pathology; Kidney Transplantation - adverse effects; Male; Middle Aged; Nephritis, Interstitial - pathology; Polyomavirus Infections - pathology; Tumor Virus Infections - pathology; Viremia - virology
• ISSN: 0301-0430
• DOI: 10.5414/CNP88FX24

Reduction of immunosuppression is a common therapeutic strategy in patients with polyomavirus nephropathy (PVN) but may be associated with acute rejection. This study aimed to evaluate the morphology of PVN in renal biopsies after reduction of immunosuppression. Eight of 241 patients who received a kidney transplant between January 2012 and December 2015 presented with BK viremia and biopsy-proven PVN. Morphological evaluation according to Banff criteria and correlation with viremia and kidney function after immunosuppression reduction was performed. PVN grades A and B were diagnosed on average 4.7 months post-transplant in 1 and 7 patients, respectively. Indication biopsies after immunosuppression reduction showed an increase in tubulitis and interstitial inflammation score compared to those at the time of the PVN diagnosis. Surveillance biopsies 1 year after transplantation revealed resolution of interstitial inflammation and tubulitis accompanied by clearance of BK viremia in 4 patients (50%), including 1 patient with rejection. One patient showed residual interstitial inflammation after viral clearance. In these patients, renal function returned to baseline. One patient with persisting low BK virus (BKV) in serum and kidney showed a decrease of tubulointerstitial inflammation but scarring was seen. Rejection occurred in 3 patients (38%). PVN-associated interstitial inflammation and tubulitis cannot be differentiated morphologically from T-cell-mediated tubulointerstitial rejection. Significant interstitial inflammation and tubulitis in PVN under low-dose immunosuppression might represent immune reconstitution injury, which is reduced after successful BKV clearance from the serum and kidney. Concomitant rejection in PVN patients on low immunosuppression might be efficiently treated with transient pulse immunosuppressive therapy.
.